Business Description
Abbott Laboratories
NAICS : 339112
SIC : 3841
ISIN : US0028241000
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | 1.4 | |||||
Interest Coverage | 10.17 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year EBITDA Growth Rate | 6.8 | |||||
3-Year EPS without NRI Growth Rate | 21.3 | |||||
3-Year FCF Growth Rate | -3.4 | |||||
3-Year Book Growth Rate | 6.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 8.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.7 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.01 | |||||
9-Day RSI | 48.34 | |||||
14-Day RSI | 49.55 | |||||
6-1 Month Momentum % | -5.84 | |||||
12-1 Month Momentum % | -4.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.6 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.47 | |||||
Days Inventory | 135.43 | |||||
Days Sales Outstanding | 57.68 | |||||
Days Payable | 83.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.01 | |||||
Dividend Payout Ratio | 0.47 | |||||
3-Year Dividend Growth Rate | 12.3 | |||||
Forward Dividend Yield % | 2.11 | |||||
5-Year Yield-on-Cost % | 3.73 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 3.27 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.1 | |||||
Operating Margin % | 15.76 | |||||
Net Margin % | 13.96 | |||||
FCF Margin % | 12.2 | |||||
ROE % | 14.89 | |||||
ROA % | 7.71 | |||||
ROIC % | 10.32 | |||||
ROC (Joel Greenblatt) % | 67.68 | |||||
ROCE % | 12.14 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 32.37 | |||||
Forward PE Ratio | 22.37 | |||||
PE Ratio without NRI | 23.67 | |||||
Shiller PE Ratio | 38.6 | |||||
Price-to-Owner-Earnings | 41.48 | |||||
PEG Ratio | 2.06 | |||||
PS Ratio | 4.51 | |||||
PB Ratio | 4.66 | |||||
Price-to-Tangible-Book | 25.34 | |||||
Price-to-Free-Cash-Flow | 36.89 | |||||
Price-to-Operating-Cash-Flow | 25.42 | |||||
EV-to-EBIT | 26.34 | |||||
EV-to-Forward-EBIT | 20.37 | |||||
EV-to-EBITDA | 18.14 | |||||
EV-to-Forward-EBITDA | 17.65 | |||||
EV-to-Revenue | 4.68 | |||||
EV-to-Forward-Revenue | 4.51 | |||||
EV-to-FCF | 38.33 | |||||
Price-to-Projected-FCF | 1.74 | |||||
Price-to-DCF (Earnings Based) | 0.88 | |||||
Price-to-DCF (FCF Based) | 1.94 | |||||
Price-to-Median-PS-Value | 1.08 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.07 | |||||
Price-to-Graham-Number | 5.16 | |||||
Earnings Yield (Greenblatt) % | 3.8 | |||||
FCF Yield % | 2.72 | |||||
Forward Rate of Return (Yacktman) % | 14.8 |